{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:39:06Z","timestamp":1792834746205,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>During the COVID-19 pandemic, vaccinations were highly beneficial to public health, preventing disease and reducing mortality. This study aimed to investigate long-term adverse clinical symptoms following COVID-19 vaccination with the Oxford AstraZeneca (ChAdOx1 nCoV-19, Oxford), Pfizer-BioNTech (BNT162b2), and Moderna (mRNA-1273) vaccines. In this cross-sectional study, the total number of participants was 429; among them, 243 (56.6%) were male, and 186 (43.4%) were female. An online Google Form was prepared in both Arabic and English and distributed to participants who received the Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines. The most common long-term adverse effects reported after COVID-19 vaccination were chronic fatigue, impaired cognitive function, and menstrual irregularity. The Moderna vaccine had a higher self-reported symptom rate among male participants (50\u201361.5%) than among female participants (33.3\u201328%). Chronic fatigue was more frequent among Oxford AstraZeneca recipients (34.7%) than among Moderna (22.2%) and Pfizer-BioNTech (27.7%) recipients. The second dose was associated with slightly higher rates of chronic fatigue among Oxford AstraZeneca recipients (38.9%) than among Moderna (25%) and Pfizer-BioNTech recipients (27.3%). For cognitive problems, the prevalence was similar across all brands (25%). Menstrual irregularity was slightly higher among females who received Pfizer-BioNTech (14.8%) than among Oxford AstraZeneca recipients (18.9%). The highest proportion of recipients who were infected after vaccination was among those who received the Oxford AstraZeneca vaccine (46.3%). In conclusion, the most commonly reported long-term adverse effects after COVID-19 vaccination were chronic fatigue, cognitive impairment, and menstrual irregularity. Further large-scale studies are required to provide more conclusive evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050282","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:01:24Z","timestamp":1787968884000},"page":"e50282","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term adverse effects following COVID-19 vaccination"],"prefix":"10.1097","volume":"105","author":[{"given":"Jehad A.","family":"Aldali","sequence":"first","affiliation":[{"name":"Department of Pathology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9820-1852","authenticated-orcid":false,"given":"Sultan Ayoub","family":"Meo","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/vaccines11020231","article-title":"Adverse effects of Pfizer (BioNTech), Oxford AstraZeneca, and Moderna COVID-19 vaccines among the adult population in Saudi Arabia: a cross-sectional study.","volume":"11","author":"Aldali","year":"2023","journal-title":"Vaccines"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jksus.2020.04.004","article-title":"Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19.","volume":"32","author":"Meo","year":"2020","journal-title":"J King Saud Univ Sci"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/vaccines11020266","article-title":"Evaluating the adverse events associated with three doses of the COVID-19 vaccination in adults in the western region of Saudi Arabia: a cross-sectional study.","volume":"11","author":"Aldali","year":"2023","journal-title":"Vaccines"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1016\/S2214-109X(21)00043-7","article-title":"An interactive website tracking COVID-19 vaccine development.","volume":"9","author":"Shrotri","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.15537\/smj.2022.43.11.20220493","article-title":"Evaluate the side effects associated with the COVID-19 vaccine on adolescents in Riyadh, Saudi Arabia.","volume":"43","author":"Aldali","year":"2022","journal-title":"Saudi Med J"},{"key":"R7-20261024","first-page":"545","article-title":"Non-pharmaceutical interventions and their relevance in the COVID-19 vaccine rollout in Saudi Arabia and Arab Gulf countries.","volume":"7","author":"Althobaity","year":"2022","journal-title":"Infect Dis Model"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review.","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/vaccines9060674","article-title":"Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia.","volume":"9","author":"Alhazmi","year":"2021","journal-title":"Vaccines"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jiph.2020.04.016","article-title":"Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience.","volume":"13","author":"Algaissi","year":"2020","journal-title":"J Infect Public Health"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijid.2021.07.052","article-title":"Safety and reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in Saudi Arabia.","volume":"110","author":"Al Bahrani","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"760047","DOI":"10.3389\/fmed.2021.760047","article-title":"BNT162b2 and ChAdOx1 SARS-CoV-2 post-vaccination side-effects among Saudi vaccinees.","volume":"8","author":"Alghamdi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"R15-20261024","first-page":"1646","article-title":"Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases.","volume":"18","author":"Yaamika","year":"2023","journal-title":"J Taibah Univ Med Sci"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"1420291","DOI":"10.3389\/fpubh.2025.1420291","article-title":"COVID-19 vaccines side effects among the general population during the pandemic: a cross-sectional study.","volume":"13","author":"Zaidi","year":"2025","journal-title":"Front Public Health"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"2039017","DOI":"10.1080\/21645515.2022.2039017","article-title":"Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia.","volume":"18","author":"Dar-Odeh","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"R18-20261024","first-page":"e49841","article-title":"The relationship between menstrual cycle irregularities and COVID-19 vaccination.","volume":"15","author":"Aljehani","year":"2023","journal-title":"Cureus"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4168\/aair.2021.13.4.526","article-title":"COVID-19 vaccine-associated anaphylaxis and allergic reactions: consensus statements of the KAAACI Urticaria\/Angioedema\/Anaphylaxis Working Group.","volume":"13","author":"Kim","year":"2021","journal-title":"Allergy Asthma Immunol Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:01:38Z","timestamp":1792832498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050282"}},"subtitle":["A comparative analysis of Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":18,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050282","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2026-06-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}